Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Clinical and Laboratory Investigation"
DOI: 10.1080/00365513.2017.1336569
Abstract: Abstract Introduction: Hepatocellular carcinoma (HCC) develops in about 3–4% of cirrhotic patients every year. The squamous cell carcinoma antigen (SCCA) has been found elevated in liver cancer specimens by immunohistochemistry, and detected in complex with… read more here.
Keywords: scca igm; igm; hepatocellular carcinoma; therapy ... See more keywords
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Gastroenterology"
DOI: 10.2147/ceg.s179832
Abstract: Background Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. It has been widely established that the early detection of HCC enables more treatment options with improvements in prognosis and survival. Objectives The… read more here.
Keywords: scca igm; mir 215; hcc; carcinoma ... See more keywords